Overview of Radiopharmaceuticals Market Size & Future Outlook
According to the latest report by MarkNtel Advisors, the Global Radiopharmaceuticals Market size is estimated to grow at a CAGR of around 10.19% from 2025-2030. This report is designed to enhance user understanding and support informed decision-making by thoroughly analyzing key market shifts, identifying gaps, exploring emerging opportunities, and assessing industry trends and competitive challenges. By combining both qualitative and quantitative data, it offers a comprehensive overview, highlighting growth prospects and providing valuable insights into competitors, helping both established companies and new entrants navigate the current market landscape.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
What are the key drivers influencing the growth of the Radiopharmaceuticals market?
This section provides a detailed analysis of the market drivers and factors is explored thoroughly below.
Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.
With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals.
How is the Radiopharmaceuticals market segmented and what are the key factors within each segment?
The Radiopharmaceuticals market has been further segmented into distinct categories. Analyzing growth within these segments allows you to identify niche opportunities, develop targeted strategies, and understand the variations in your core application areas and target markets.
By Radioisotope
- Technetium 99- Market Size & Forecast 2020-2030, USD Million
- Fluorine 18- Market Size & Forecast 2020-2030, USD Million
- Iodine 131- Market Size & Forecast 2020-2030, USD Million
- Gallium 68- Market Size & Forecast 2020-2030, USD Million
- Iodine 123- Market Size & Forecast 2020-2030, USD Million
- Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million
By Indication
- Oncology- Market Size & Forecast 2020-2030, USD Million
- Cardiology- Market Size & Forecast 2020-2030, USD Million
- Gastroenterology- Market Size & Forecast 2020-2030, USD Million
- Nephrology- Market Size & Forecast 2020-2030, USD Million
- Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million
By Type
- Diagnostic- Market Size & Forecast 2020-2030, USD Million
- Therapeutic- Market Size & Forecast 2020-2030, USD Million
By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million
- Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific.
Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html
Who are the Key Market Players in the Radiopharmaceuticals industry?
The competitive landscape of the Radiopharmaceuticals market provides a detailed look at the key players in the industry. This includes an overview of each company, their financial performance, revenue generation, and market potential. It also covers their investments in R&D, new market initiatives, production facilities, and strengths and weaknesses. Additionally, the analysis looks at recent product launches, approvals, the range of products offered, their dominance in different applications, and the product life cycle. All of this information is specifically focused on how each company is positioning itself within the market.
Several key players are actively operating in the market, including
- Bayer AG
- Iso-Tex Diagnostics, Inc.
- Jubilant Pharmova Limited
- Novartis AG
- General Electric Company
- Lantheus Holdings, Inc.
- Eli Lilly and Company
- Siemens Healthineers AG
- Curium Pharma
- Cardinal Health
- Blue Earth Diagnostics, Inc. (Bracco Group)
- Acrotech Biopharm
- Northstar Medical Technologies LLC
- IBA Radiopharma Solutions
- Sun Pharmaceutical Industries, Inc.
Market Advancement by Leading Companies:
- 2023: Curium Pharma announced that the European Commission has granted marketing authorization for PYLCLARI™, a radiopharmaceutical indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in adults with prostate cancer.
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
Other Report:
- https://www.blogger.com/blog/post/preview/1174872584837895911/2759035857559419729
- https://uberant.com/article/2064901-baby-pacifier-market-expected-to-expand-at-a-remarkable-cagr-of-621-through-2023-2028/
- https://globalriskcommunity.com/notes/e-cigarette-market-expected-to-expand-at-a-remarkable-cagr-of-3-3
- https://medium.com/@amitkumarmarkntel/coronary-stents-market-expected-to-expand-at-a-remarkable-cagr-of-6-9-through-2022-2027-48981b9aa29c
Why Choose MarkNtel Advisors:
- Focused Industry Expertise
- Diverse Report Offerings
- Personalized Research Solutions
- Robust Research Methodology
- In-depth Report Coverage
- Tracking Technological Advancements
- Comprehensive Value-Chain Analysis
- Discovering Market Opportunities
- Analyzing Growth Trajectories
- Assured Quality Insights
- Dedicated After-Sales Support
- Trusted by Fortune 500 Companies
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call + +1 628 895 8081, +91 120 4278433
Email: sales@marknteladvisors.com
